Institut du Cancer de Montpellier - Val d'Aurelle
New trial — Analysis of Circulating Tumor Markers in Blood
New trial
68/100
Opportunity
Commercial fit23/25
Clinical timing11/20
Biomarker need15/20
Relationship2/10
Signal strength9/10
Account value7/10
Urgency1/5
New not applicable trial NCT04025541 posted by Institut du Cancer de Montpellier - Val d'Aurelle: "Analysis of Circulating Tumor Markers in Blood". New trial on a not applicable recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).
Why nowClinicalTrials.gov record updated 524 days ago.
ConfidenceHigh · 95%